We are live on
!
Find out more
SNS Financial Group Portfolio holdings
AUM
$5.2B
Turnover
64.09%
1-Year Est. Return
22.05%
This Fund
S&P 500
This Quarter
Est. Return
+1.85%
1 Year Est. Return
+22.05%
3 Year Est. Return
+54.19%
5 Year Est. Return
+56.11%
10 Year Est. Return
+187.71%
AUM
$398M
AUM Growth
+$5.3M
(+1.4%)
Cap. Flow
-$640K
Cap. Flow
% of AUM
-0.16%
Top 10 Holdings %
Top 10 Hldgs %
58.12%
Holding
138
New
23
Increased
54
Reduced
40
Closed
9
Avg Time Held Equity + Options
1.4
years
Top 10 Avg Time Held Equity + Options
1.6
years
Top 20 Avg Time Held Equity + Options
1.3
years
Avg Time Held Equity only
1.5
years
Top 10 Avg Time Held Equity only
1.8
years
Top 20 Avg Time Held Equity only
1.3
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
AbbVie
ABBV
|
+$4.83M |
| 2 |
State Street SPDR S&P 500 ETF Trust
SPY
|
+$3.64M |
| 3 |
iShares MSCI EAFE ETF
EFA
|
+$2.57M |
| 4 |
iShares Core S&P 500 ETF
IVV
|
+$2.3M |
| 5 |
iShares Russell 2000 ETF
IWM
|
+$1.84M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Vanguard Short-Term Treasury ETF
VGSH
|
+$11.5M |
| 2 |
Gilead Sciences
GILD
|
+$4.15M |
| 3 |
iShares 20+ Year Treasury Bond ETF
TLT
|
+$2.68M |
| 4 |
Pfizer
PFE
|
+$1.53M |
| 5 |
AT&T
T
|
+$1.51M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Miscellaneous | 72.71% |
| 2 | Technology | 6.24% |
| 3 | Financials | 4.18% |
| 4 | Industrials | 3.93% |
| 5 | Consumer Discretionary | 3.19% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
76
Vanguard S&P 500 ETF
VOO
$1.05T
| $622K | 0.16% |
3,236
-3,044
| -48% | -$579K |
2016 Q1
1 quarter
|
|
77
ExxonMobil
XOM
$718B
| $608K | 0.15% |
6,484
+110
| +2% | +$9.73K |
2014 Q2
8 quarters
|
|
78
Johnson & Johnson
JNJ
$610B
| $602K | 0.15% |
4,964
+2,584
| +109% | +$294K |
2013 Q2
12 quarters
|
|
79
JPMorgan Diversified Return International Equity ETF
JPIN
$384M
| $570K | 0.14% |
+11,525
| New | +$573K |
2016 Q2
0 quarters
|
|
80
iShares MSCI EAFE Growth ETF
EFG
$15B
| $561K | 0.14% |
8,582
+407
| +5% | +$26.9K |
2015 Q2
4 quarters
|
|
81
First Trust Multi Cap Value AlphaDEX Fund
FAB
$159M
| $543K | 0.14% |
12,790
-1,470
| -10% | -$62.9K |
2014 Q2
8 quarters
|
|
82
Wells Fargo
WFC
$248B
| $536K | 0.13% |
11,329
+2,005
| +22% | +$97.8K |
2013 Q4
10 quarters
|
|
83
CALL
Biogen
BIIB
$34.8B
| $530K | 0.13% |
+2,000
| New | +$527K |
2016 Q2
0 quarters
|
|
|
GIVE
84
DELISTED
AdvisorShares Global Echo ETF
GIVE
| $526K | 0.13% |
8,847
-896
| -9% | -$53.3K |
2013 Q3
11 quarters
|
|
85
Oracle
ORCL
$408B
| $518K | 0.13% |
12,649
+899
| +8% | +$35.9K |
2015 Q1
5 quarters
|
|
86
Alphabet (Google) Class C
GOOG
$4.22T
| $514K | 0.13% |
14,860
+1,460
| +11% | +$52.4K |
2015 Q4
2 quarters
|
|
87
iShares S&P Small-Cap 600 Growth ETF
IJT
$7.57B
| $504K | 0.13% |
7,850
-16,610
| -68% | -$1.04M |
2013 Q2
12 quarters
|
|
88
Vanguard FTSE Developed Markets ETF
VEA
$228B
| $497K | 0.12% |
14,052
-12,247
| -47% | -$442K |
2014 Q2
8 quarters
|
|
89
Honeywell
HON
$66.7B
| $496K | 0.12% |
4,742
-111
| -2% | -$11.4K |
2015 Q1
5 quarters
|
|
90
iShares S&P 500 Growth ETF
IVW
$78.2B
| $442K | 0.11% |
15,176
-35,472
| -70% | -$1.03M |
2013 Q2
12 quarters
|
|
91
Bristol-Myers Squibb
BMY
$124B
| $439K | 0.11% |
5,971
+467
| +8% | +$33K |
2013 Q4
10 quarters
|
|
92
Verizon
VZ
$184B
| $435K | 0.11% |
7,798
-858
| -10% | -$44.5K |
2013 Q4
10 quarters
|
|
93
Altria Group
MO
$123B
| $430K | 0.11% |
6,237
-22,778
| -79% | -$1.46M |
2013 Q2
12 quarters
|
|
94
Abbott
ABT
$181B
| $421K | 0.11% |
10,706
+1,700
| +19% | +$67.7K |
2014 Q2
8 quarters
|
|
95
iShares S&P Mid-Cap 400 Growth ETF
IJK
$10.5B
| $420K | 0.11% |
9,932
-25,252
| -72% | -$1.05M |
2013 Q2
12 quarters
|
|
|
ETP
96
DELISTED
Energy Transfer Partners L.p.
ETP
| $417K | 0.1% |
10,966
+3,500
| +47% | +$125K |
2014 Q2
8 quarters
|
|
97
CALL
Apple
AAPL
$4.99T
| $379K | 0.1% |
16,000
+1,200
| +8% | +$29.8K |
2015 Q1
5 quarters
|
|
98
Chevron
CVX
$430B
| $342K | 0.09% |
3,266
+386
| +13% | +$38.8K |
2015 Q4
2 quarters
|
|
99
IBM
IBM
$221B
| $328K | 0.08% |
2,264
+46
| +2% | +$6.58K |
2013 Q2
12 quarters
|
|
100
MidCap Financial Investment
MFIC
$700M
| $327K | 0.08% |
19,667
| – | – |
2015 Q2
4 quarters
|
|
Similar funds
DFO
SNS Financial Group's Q2 2016 Portfolio in Review
As of Q2 2016, SNS Financial Group held 138 positions worth $398M, up 1.4% from $393M the previous quarter. Its ten largest holdings account for 58% of the portfolio.
SNS Financial Group's Q2 2016 filing shows 23 new, 54 increased, 40 reduced and 9 closed positions. Its largest new stake was Home Depot: 13,087 shares worth $1.67M. The largest sale was Vanguard Short-Term Treasury ETF, an estimated $11.5M.
By sector, the portfolio is most concentrated in Miscellaneous at 73% of assets, up from 72% a quarter earlier, followed by Technology and Financials.
- SNS Financial Group's largest Q2 2016 buy was Home Depot: 13,087 shares worth $1.67M.
- SNS Financial Group added most to AbbVie in Q2 2016, an estimated $4.83M increase.
- SNS Financial Group's biggest Q2 2016 reduction was Pfizer, cutting an estimated $1.53M.
- SNS Financial Group fully exited Vanguard Short-Term Treasury ETF in Q2 2016, selling an estimated $11.5M.
- SNS Financial Group's ten largest holdings make up 58% of its $398M portfolio in Q2 2016.
- SNS Financial Group opened 23 new positions and closed 9 in Q2 2016.
- SNS Financial Group's portfolio value rose 1.4% quarter-over-quarter to $398M.
Based on SNS Financial Group's 13F filing for Q2 2016, filed 16 Aug 2016.